Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.33
+0.05 (0.80%)
At close: Jul 6, 2026, 4:00 PM EDT
6.33
0.00 (0.00%)
After-hours: Jul 6, 2026, 4:10 PM EDT
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,463,391
Market Cap
663.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -3 | -15.00% |
| Dec 31, 2023 | 20 | 6 | 42.86% |
| Dec 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 10 | -4 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 196 |
| Omeros | 175 |
| BridgeBio Oncology Therapeutics | 106 |
| SpyGlass Pharma | 68 |
| Achieve Life Sciences | 28 |
| Bright Minds Biosciences | 26 |
RLMD News
- 7 days ago - Relmada Therapeutics joins Russell 2000, Russell 3000 Indexes - TheFly
- 7 days ago - Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 18 days ago - Relmada Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 25 days ago - Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program - GlobeNewsWire
- 27 days ago - Relmada Therapeutics Slides: Corporate presentation - Filings
- 4 weeks ago - Relmada Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Relmada Therapeutics Transcript: AGM 2026 - Transcripts